At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Posted on: 24 June, 2025
A fascinating and informative podcast has been launched showcasing groundbreaking research, in..... Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 24 June, 2025
The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the p..... Read more
Category: Awards, Cardiovascular and Renal Research, Funding support, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 23 June, 2025
Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first st..... Read more
Category: New Treatment, Research Excellence